Bright Green (BGXX) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BGXX vs. NBRV, VRCA, MIST, OTLK, QNCX, TNYA, BLUE, MRSN, IPSC, and PEPGShould you be buying Bright Green stock or one of its competitors? The main competitors of Bright Green include Nabriva Therapeutics (NBRV), Verrica Pharmaceuticals (VRCA), Milestone Pharmaceuticals (MIST), Outlook Therapeutics (OTLK), Quince Therapeutics (QNCX), Tenaya Therapeutics (TNYA), bluebird bio (BLUE), Mersana Therapeutics (MRSN), Century Therapeutics (IPSC), and PepGen (PEPG). These companies are all part of the "pharmaceutical products" industry. Bright Green vs. Nabriva Therapeutics Verrica Pharmaceuticals Milestone Pharmaceuticals Outlook Therapeutics Quince Therapeutics Tenaya Therapeutics bluebird bio Mersana Therapeutics Century Therapeutics PepGen Nabriva Therapeutics (NASDAQ:NBRV) and Bright Green (NASDAQ:BGXX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, community ranking, profitability, institutional ownership, risk, analyst recommendations and valuation. Is NBRV or BGXX more profitable? Bright Green has a net margin of 0.00% compared to Nabriva Therapeutics' net margin of -148.11%. Bright Green's return on equity of -88.37% beat Nabriva Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Nabriva Therapeutics-148.11% -365.53% -135.81% Bright Green N/A -88.37%-55.30% Does the media refer more to NBRV or BGXX? In the previous week, Nabriva Therapeutics had 1 more articles in the media than Bright Green. MarketBeat recorded 1 mentions for Nabriva Therapeutics and 0 mentions for Bright Green. Nabriva Therapeutics' average media sentiment score of 0.00 equaled Bright Green'saverage media sentiment score. Company Overall Sentiment Nabriva Therapeutics Neutral Bright Green Neutral Which has better earnings and valuation, NBRV or BGXX? Bright Green has lower revenue, but higher earnings than Nabriva Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNabriva Therapeutics$35.59M0.00-$57.19M-$19.20N/ABright GreenN/AN/A-$13.13M-$0.06N/A Do institutionals & insiders have more ownership in NBRV or BGXX? 0.3% of Nabriva Therapeutics shares are owned by institutional investors. Comparatively, 7.8% of Bright Green shares are owned by institutional investors. 1.6% of Nabriva Therapeutics shares are owned by company insiders. Comparatively, 62.5% of Bright Green shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community favor NBRV or BGXX? Nabriva Therapeutics received 393 more outperform votes than Bright Green when rated by MarketBeat users. CompanyUnderperformOutperformNabriva TherapeuticsOutperform Votes39354.74% Underperform Votes32545.26% Bright GreenN/AN/A Which has more risk & volatility, NBRV or BGXX? Nabriva Therapeutics has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Comparatively, Bright Green has a beta of -0.26, meaning that its share price is 126% less volatile than the S&P 500. SummaryBright Green beats Nabriva Therapeutics on 7 of the 12 factors compared between the two stocks. Get Bright Green News Delivered to You Automatically Sign up to receive the latest news and ratings for BGXX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGXX vs. The Competition Export to ExcelMetricBright GreenMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.47M$1.17B$5.30B$7.35BDividend YieldN/AN/A5.12%4.30%P/E Ratio-1.009.9221.8017.80Price / SalesN/A7.44379.9697.74Price / CashN/A10.4038.2634.64Price / BookN/A1.216.443.98Net Income-$13.13M-$56.07M$3.21B$247.73M Bright Green Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownNBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070VRCAVerrica Pharmaceuticals3.6937 of 5 stars$0.49-10.8%$9.50+1,825.4%-93.1%$45.28M$7.57M-0.2740Short Interest ↑Gap DownMISTMilestone Pharmaceuticals1.4836 of 5 stars$0.83+0.3%$17.00+1,937.4%-49.2%$44.52M$1M-1.0330Short Interest ↑Negative NewsGap UpOTLKOutlook Therapeutics1.4047 of 5 stars$1.39flat$10.20+633.8%-83.2%$44.50MN/A-0.1920QNCXQuince Therapeutics2.0719 of 5 stars$1.01-1.0%$8.00+692.1%-0.9%$44.44MN/A-0.8160Gap DownTNYATenaya Therapeutics3.0553 of 5 stars$0.51+3.6%$6.25+1,131.8%-89.5%$44.44MN/A-0.35110Gap UpBLUEbluebird bio2.5945 of 5 stars$4.47-6.1%$44.60+897.8%-78.5%$43.76M$83.81M-0.12520MRSNMersana Therapeutics3.2537 of 5 stars$0.35+5.2%$4.00+1,047.8%-89.9%$43.43M$40.50M-0.57150IPSCCentury Therapeutics1.9987 of 5 stars$0.50+0.4%$4.40+778.2%-80.9%$43.11M$6.59M-0.27170PEPGPepGen2.6939 of 5 stars$1.31+19.1%$10.33+688.8%-88.4%$42.83MN/A-0.4430 Related Companies and Tools Related Companies NBRV Alternatives VRCA Alternatives MIST Alternatives OTLK Alternatives QNCX Alternatives TNYA Alternatives BLUE Alternatives MRSN Alternatives IPSC Alternatives PEPG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGXX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Green Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Green With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGXX Stock Free BGXX Stock Alerts